RT Journal Article
SR Electronic
T1 Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006270
DO 10.1136/jitc-2022-006270
VO 11
IS 5
A1 Chesney, Jason A
A1 Puzanov, Igor
A1 Collichio, Frances A
A1 Singh, Parminder
A1 Milhem, Mohammed M
A1 Glaspy, John
A1 Hamid, Omid
A1 Ross, Merrick
A1 Friedlander, Philip
A1 Garbe, Claus
A1 Logan, Theodore
A1 Hauschild, Axel
A1 Lebbé, Celeste
A1 Joshi, Harshada
A1 Snyder, Wendy
A1 Mehnert, Janice M
YR 2023
UL http://jitc.bmj.com/content/11/5/e006270.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.